CPhA pushing bill to allow California pharmacists to perform OTC lab tests
April 17th 2012California pharmacists would be able to better assist patients with increasingly more complicated over-the-counter assessment tests if the state?s Senate approves new legislation, according to Jon Roth, CEO, California Pharmacists Association.
No benefit of B vitamins or omega-3 on cancer outcomes, study finds
February 23rd 2012There are no beneficial effects of supplementation with relatively low doses of B vitamins and/or omega-3 fatty acids on cancer outcomes in individuals with prior cardiovascular disease, according to a study published online February 13 in the Archives of Internal Medicine.
Infants' Tylenol medication recalled by McNeil after dosing-system complaints
February 21st 2012More than a half million bottles of Infants' Tylenol Oral Suspension, 1 oz. grape, have been recalled voluntarily by McNeil Consumer Healthcare because of complaints about using the dosing system, the company announced.
ISMP cautions about new acetaminophen labeling for infants
December 1st 2011Liquid acetaminophen for infants is being shipped to hospitals and drug stores in new concentrations, even though manufacturers may not be providing notice about the concentration change, according to the Institute for Safe Medication Practices.
OTC product news for pharmacists (September 2011)
September 19th 2011In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. Look for more OTC Product News in upcoming issues of the Community Pharmacists? Report.
OTC product news for pharmacists: August 2011
August 22nd 2011In this section we showcase products and product news that ran up against space limitations or fell outside the parameters of recently featured categories in the print edition. Look for more OTC Product News in upcoming issues of the Community Pharmacists? Report.
FDA approves OTC antifungal Tolnaftate-D
August 19th 2011Apricus Biosciences and its wholly owned subsidiary, NexMed USA, have received FDA approval for over-the-counter sales of antifungal drug Tolnaftate-D, containing the company's NexACT technology, which transiently loosens the tight junction between the cells of the sealed skin to allow more permeation.
Tylenol dose lowered to prevent overdose risk
August 1st 2011Johnson and Johnson has announced plans for new dosing instructions that lower the maximum daily dose for single-ingredient Extra Strength Tylenol (acetaminophen) products sold in the United States from 8 pills per day (4,000 mg) to 6 pills per day (3,000 mg).